Thus, blocking specific GluR signaling, which is exploited by tumors to survive and grow, and enhance tumor-promoting inflammation, could be a potential therapeutic approach to treat tumors and some autoimmune inflammatory diseases. This evidence concerns the gene GSR and neoplasm.